Lyn Balsamo, PhD
DownloadHi-Res Photo
Cards
Contact Info
Pediatric Hematology & Oncology
333 Cedar Street/LMP 2073, P.O. Box 208064
New Haven, CT 06520
United States
About
Titles
Associate Research Scientist in Pediatrics (Hematology / Oncology)
Appointments
Pediatric Hematology & Oncology
Associate Research ScientistPrimary
Other Departments & Organizations
- Pediatric Hematology & Oncology
- Pediatric Hematology & Oncology Program
- Pediatric HEROS Survivorship Program
- Pediatric Neuropsychological Program
- Pediatrics
- Yale Cancer Center
- Yale Medicine
Education & Training
- Fellow
- Yale University School of Medicine (2009)
- Fellow
- Institute of Living/Hartford Hospital (2004)
- Intern
- Institute of Living/Hartford Hospital (2003)
- PhD
- American University (2003)
Research
Overview
Medical Subject Headings (MeSH)
Hematology; Mental Health; Neurocognitive Disorders; Pediatrics; Psychology, Medical; Psycho-Oncology
ORCID
0000-0003-3703-2623
Research at a Glance
Yale Co-Authors
Frequent collaborators of Lyn Balsamo's published research.
Publications Timeline
A big-picture view of Lyn Balsamo's research output by year.
Research Interests
Research topics Lyn Balsamo is interested in exploring.
Farzana Pashankar, MD, MRCP, MBBS
Mary Jane Hogan, MD, MPH, FAAP
Matthew Grossman, MD
Michael B. Bracken, PhD, MPH, FACE
Xiaomei Ma, PhD
31Publications
2,027Citations
Neurocognitive Disorders
Publications
2022
Sense of mastery and attitude towards illness: Examining longitudinal benefits of a medical specialty camp for youth with sickle cell disease
Gillard A, Gagnon R, Pashankar F, Balsamo L, Grafft N, Miranda J, Boruchov D, Neri C, Sprinz P, Longyear C. Sense of mastery and attitude towards illness: Examining longitudinal benefits of a medical specialty camp for youth with sickle cell disease. Clinical Child Psychology And Psychiatry 2022, 28: 1012-1023. PMID: 36503316, DOI: 10.1177/13591045221145425.Peer-Reviewed Original ResearchCitationsMeSH Keywords and Concepts
2019
3.22 EMOTION REGULATION IN PEDIATRIC SICKLE CELL PATIENTS: ASSOCIATIONS WITH SYMPTOMS OF DEPRESSION, ANXIETY, AND PAIN INTERFERENCE
Miller M, Bailey C, Pashankar F, Balsamo L. 3.22 EMOTION REGULATION IN PEDIATRIC SICKLE CELL PATIENTS: ASSOCIATIONS WITH SYMPTOMS OF DEPRESSION, ANXIETY, AND PAIN INTERFERENCE. Journal Of The American Academy Of Child & Adolescent Psychiatry 2019, 58: s202. DOI: 10.1016/j.jaac.2019.08.185.Peer-Reviewed Original ResearchMonitoring neurocognitive functioning in childhood cancer survivors: evaluation of CogState computerized assessment and the Behavior Rating Inventory of Executive Function (BRIEF)
Balsamo LM, Mitchell HR, Ross W, Metayer C, Hardy KK, Kadan-Lottick NS. Monitoring neurocognitive functioning in childhood cancer survivors: evaluation of CogState computerized assessment and the Behavior Rating Inventory of Executive Function (BRIEF). BMC Psychology 2019, 7: 26. PMID: 31046815, PMCID: PMC6498488, DOI: 10.1186/s40359-019-0302-3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBehavior Rating InventoryFull neuropsychological evaluationRating InventoryNeuropsychological evaluationChildhood cancer survivorsGrade-level performanceComprehensive neuropsychological testingCancer survivorsExecutive functionNeurocognitive functioningPsychosocial functioningAcademic difficultiesNeuropsychological testingComputerized assessmentNeurocognitive impairmentNeed of evaluationFunctioningReadingImproving Care for Sickle Cell Pain Crisis Using a Multidisciplinary Approach
Balsamo L, Shabanova V, Carbonella J, Szondy MV, Kalbfeld K, Thomas DA, Santucci K, Grossman M, Pashankar F. Improving Care for Sickle Cell Pain Crisis Using a Multidisciplinary Approach. Pediatrics 2019, 143: e20182218. PMID: 30944154, DOI: 10.1542/peds.2018-2218.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsVaso-occlusive crisisHospital daysReadmission ratesHospital costsSickle cell disease vaso-occlusive crisisMultidisciplinary quality improvement projectSickle cell pain crisisThirty-day readmission ratesDedicated team effortSCD pediatric patientsPatients ages 0Direct hospital costsLength of stayHigh usersStudy-Act methodologyQuality improvement projectMental health providersHigh-use groupPain planPain crisisFrequent hospitalizationsRisk patientsPediatric patientsPreintervention periodEmergency department
2018
Parental perception of child vulnerability in childhood cancer survivors
Hogan M, Ross WL, Balsamo L, Mitchell H, Kadan‐Lottick N. Parental perception of child vulnerability in childhood cancer survivors. Pediatric Blood & Cancer 2018, 65: e27364. PMID: 30024087, DOI: 10.1002/pbc.27364.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsChildhood cancer survivorsCancer survivorsLate complicationsCancer historyPercent of parentsCurrent health statusCurrent mean ageChild Vulnerability ScalePatient sociodemographicsClinic visitsCohort studySurvivorship clinicPediatric patientsTherapy completionYears posttherapyMean ageMedical recordsLower riskHealth statusComplicationsChild vulnerabilityCancer treatmentSurvivorsTreatment intensityCancer diagnosisLong‐term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study
Zheng DJ, Krull KR, Chen Y, Diller L, Yasui Y, Leisenring W, Brouwers P, Howell R, Lai J, Balsamo L, Oeffinger KC, Robison LL, Armstrong GT, Kadan‐Lottick N. Long‐term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Cancer 2018, 124: 3220-3230. PMID: 29888538, PMCID: PMC6168938, DOI: 10.1002/cncr.31379.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBehavior Problem IndexPsychological impairmentChronic health conditionsNeuroblastoma survivorsElevated riskAdult educational attainmentMultivariate log-binomial modelsMore chronic health conditionsPrevalence of impairmentPsychological functioningHealth conditionsAttention deficitsChildhood cancer survivorsAntisocial behaviorHigh-risk groupAnxiety/depressionEducational attainmentSocial withdrawalLog-binomial modelsNeurotoxic treatmentMedian agePeripheral neuropathyYear survivorsPulmonary diseaseCancer survivors
2017
Longitudinal analysis of quality‐of‐life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial
Zheng DJ, Lu X, Schore RJ, Balsamo L, Devidas M, Winick NJ, Raetz EA, Loh ML, Carroll WL, Sung L, Hunger SP, Angiolillo AL, Kadan‐Lottick N. Longitudinal analysis of quality‐of‐life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial. Cancer 2017, 124: 571-579. PMID: 29112230, PMCID: PMC5808870, DOI: 10.1002/cncr.31085.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAverage-risk acute lymphoblastic leukemiaQuality of lifeEmotional impairmentsLife Inventory (PedsQL) Generic CoreHigh-risk patientsProspective cohort studyTime of diagnosisEnd of therapyAcute lymphoblastic leukemiaFamily-based interventionsCohort studyQoL impairmentMean ageLymphoblastic leukemiaQOL outcomesPediatric QualityProportion of individualsEarly screeningPopulation normsImpaired rangeImpairmentMonthsTime pointsFunctioning impairmentImpairment patternsLongitudinal analysis of quality of life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children’s Oncology Group (COG) AALL0932.
Zheng D, Lu X, Ross W, Angiolillo A, Schore R, Balsamo L, Devidas M, Whitley M, Kadan-Lottick N. Longitudinal analysis of quality of life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children’s Oncology Group (COG) AALL0932. Journal Of Clinical Oncology 2017, 35: 10522-10522. DOI: 10.1200/jco.2017.35.15_suppl.10522.Peer-Reviewed Original ResearchConceptsAverage-risk acute lymphoblastic leukemiaQuality of lifeAcute lymphoblastic leukemiaLymphoblastic leukemiaEmotional functioningMulti-agent chemotherapyEvent-free survivalModifiable risk factorsFrequent hospital visitsEmotional impairmentsMedian ageHospital visitsPattern of impairmentQOL outcomesRisk factorsPainful proceduresFamily functioningProportion of individualsEarly screeningSevere impairmentPopulation normsPotential predictorsImpaired rangeLife outcomesMonthsThe Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment
Viola A, Balsamo L, Neglia JP, Brouwers P, Ma X, Kadan-Lottick NS. The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment. Journal Of Pediatric Hematology/Oncology 2017, 39: 174-178. PMID: 28085741, PMCID: PMC5364064, DOI: 10.1097/mph.0000000000000761.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLeukemia survivorsNeurocognitive impairmentAttention-deficit/hyperactivity disorder (ADHD) outcomesPediatric acute lymphoblastic leukemia survivorsPediatric acute lymphoblastic leukemia treatmentAcute lymphoblastic leukemia survivorsAcute lymphoblastic leukemia treatmentPotential late effectsAcute lymphoblastic leukemiaMultivariate logistic regressionExecutive Function Parent FormCross-sectional studyOngoing clinical careBehavior Rating InventoryComprehensive neuropsychological assessmentElevated scoresFirst remissionClinical outcomesLymphoblastic leukemiaLate effectsClinical careRating InventoryLeukemia treatmentCognitive impairmentIndex score
2016
Prevalence and predictors of anxiety and depression after completion of chemotherapy for childhood acute lymphoblastic leukemia: A prospective longitudinal study
Kunin-Batson AS, Lu X, Balsamo L, Graber K, Devidas M, Hunger SP, Carroll WL, Winick NJ, Mattano LA, Maloney KW, Kadan-Lottick NS. Prevalence and predictors of anxiety and depression after completion of chemotherapy for childhood acute lymphoblastic leukemia: A prospective longitudinal study. Cancer 2016, 122: 1608-1617. PMID: 27028090, PMCID: PMC4860039, DOI: 10.1002/cncr.29946.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAcute lymphoblastic leukemiaCompletion of treatmentGreater riskEmotional-behavioral functioningChildren's Oncology Group protocolsChildhood acute lymphoblastic leukemiaAdjusted longitudinal analysesCompletion of chemotherapyDepressive symptoms 6 monthsSymptoms 6 monthsEmotional distressElevated anxiety scoresAnxiety 1 monthStandardized rating scalesElevated depression scoresChildren's emotional-behavioral functioningLymphoblastic leukemiaPredictors of anxietySocial support copingMeasures of copingDepressive symptomsGeneral populationDepression scoresPsychosocial interventionsEarly screening
Clinical Care
Overview
Clinical Specialties
Pediatrics; Pediatric Hematology & Oncology; Pediatric Neuropsychology; Psychology
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileLinks & Media
News
- July 16, 2018
Pediatric Cancer Survivors Day Blasts Off!
Get In Touch
Contacts
Email
Academic Office Number
Appointment Number
Clinic Fax Number
Mailing Address
Pediatric Hematology & Oncology
333 Cedar Street/LMP 2073, P.O. Box 208064
New Haven, CT 06520
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.